Combined bendamustine, prednisone and bortezomib (BPV) in patients with relapsed or refractory multiple myeloma. [electronic resource]
Producer: 20130418Description: 499-508 p. digitalISSN:- 1432-1335
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Bendamustine Hydrochloride
- Boronic Acids -- administration & dosage
- Bortezomib
- Drug Resistance, Neoplasm -- drug effects
- Female
- Humans
- Male
- Middle Aged
- Multiple Myeloma -- drug therapy
- Nitrogen Mustard Compounds -- administration & dosage
- Prednisone -- administration & dosage
- Pyrazines -- administration & dosage
- Recurrence
- Retrospective Studies
No physical items for this record
Publication Type: Evaluation Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.